Mirror Therapy on Motor Recovery and Pain of Hemiparetic Arm

March 14, 2026 updated by: Heba Abubakr Mohamed Salama, Mansoura University

The Impact of Mirror Therapy on Motor Recovery and Pain of Hemiparetic Arm Post Stroke: A Randomized Controlled Trial

evaluate the effect of mirror therapy on motor recovery and pain of hemiparetic arm post stroke

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
    • Mansoura
      • Al Mansurah, Mansoura, Egypt, 35516
        • Faculty of Nursing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • First stroke attack (ischemic and haemorrhagic )
  • Unilateral stroke with hemiparesis
  • Able to understand simple verbal language

Exclusion Criteria:

  • Severe cognitive impairments.
  • Orthopedic or rheumatologic problems restricting upper extremity motor function.
  • Contraindications to mirror therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: control
usual hospitl care
Other: Control
the control group receive usual hospital care
Experimental: mirror group
Other: Control
the control group receive usual hospital care
Other: technique
the participant performs arm exercise behind mirror

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor Function Assessment
Time Frame: 3 weeks

measured by Fugl-Meyer Assessment for upper limb motor function. to describe impairment severity, quantify motor recovery, guide treatment planning, and evaluate outcomes. The scale comprises five domains with a maximum total score of 226 points (Motor 100; Sensation 24; Balance 14; Joint ROM 44; Joint Pain 44).

Scoring is based on direct observation of performance. Scale items are scored on the basis of ability to complete the item using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully. The total possible scale score is 226.

Points are divided among the domains as follows:

Motor score: ranges from 0 (hemiplegia) to 100 points (normal motor performance). Divided into 66 points for upper extremity and 34 points for the lower extremity.

Sensation: ranges from 0 to 24 points. Divided into 8 points for light touch and 16 points for position sense.

Balance: ranges from 0 to 14 points. Divided into 6 points for sitting and 8 points for standing.
3 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional independence
Time Frame: 3 weeks

Functional independence (measured by Modified Rankin Scale). it is a 7-point scale (0-6) that measures disability after a stroke or neurological event, assessing the ability to perform daily activities, from no disability (0) to death (6).

The Modified Rankin Scale Grade mRS 0 No symptoms at all

  1. No significant disability: despite symptoms, able to carry out all usual duties and activities
  2. Slight disability: unable to perform all previous activities but able to look after own affairs without assistance
  3. Moderate disability: requiring some help but able to walk without assistance
  4. Moderately severe disability: unable to walk without assistance and attend to own bodily needs without assistance
  5. Severe disability: bedridden, incontinence, and requiring constant nursing care and attention
  6. Death
3 weeks
Pain assessment
Time Frame: 3 weeks

Pain assessment (measured by Numeric Pain Rating Scale.) it is a 11-point scale (0-10) where patients rate their pain intensity, with 0 meaning no pain and 10 representing the worst imaginable pain.

scoring system 0: No Pain 1-3: Mild Pain 4-6: Moderate Pain 7-10: Severe Pain
3 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mansoura University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2025

Primary Completion (Actual)

February 15, 2026

Study Completion (Estimated)

April 1, 2026

Study Registration Dates

First Submitted

January 4, 2026

First Submitted That Met QC Criteria

January 13, 2026

First Posted (Actual)

January 22, 2026

Study Record Updates

Last Update Posted (Actual)

March 17, 2026

Last Update Submitted That Met QC Criteria

March 14, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Mirror therapy

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemiparesis

Clinical Trials on Control

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe